
PNZ-D 30mg/40mg Capsule PR
Marketer
Cachet Pharmaceuticals Pvt Ltd
Salt Composition
Domperidone (30mg) + Pantoprazole (40mg)
Overview PNZ-D 30mg/40mg Capsule PR
The prescription medication, PNZ-D 30mg/40mg Capsule PR, offers relief from gastroesophageal reflux disease (GERD), indigestion (dyspepsia), and gastritis. Its action centers on reducing stomach acid, thus alleviating symptoms like heartburn, abdominal pain, and irritation. This medication also neutralizes existing stomach acid and facilitates gas expulsion, easing discomfort. Administered without food, dosage and duration are determined by your physician based on individual response and condition. Continued use, as directed, is crucial; premature cessation may lead to symptom recurrence and disease exacerbation. Comprehensive disclosure of all other medications to your healthcare provider is essential due to potential drug interactions. Common, generally transient, side effects include diarrhea, nausea, abdominal pain, flatulence, dry mouth, and headache. Report any concerning side effects immediately. Drowsiness and dizziness are possible; avoid activities requiring alertness until the drug's effects are known. Alcohol consumption should be avoided due to increased sedation risk. Lifestyle adjustments, such as consuming cool milk and abstaining from hot beverages, spicy foods, and chocolate, can enhance treatment efficacy. Prior to commencing treatment, disclose any kidney or liver conditions, pregnancy, pregnancy plans, or breastfeeding to your doctor.
Uses of PNZ-D 30mg/40mg Capsule PR
Managing acid reflux, indigestion, and gastritis.
Major Benefits of PNZ-D 30mg/40mg Capsule PR:
Follow your doctor's instructions or the package leaflet for proper administration. Take one PNZ-D 30mg/40mg Capsule PR on an empty stomach.
Common Side effects of PNZ-D 30mg/40mg Capsule PR:
- Diarrhea
- Stomach pain
- Flatulence
- Dryness in mouth
- Dizziness
- Headache
How to use PNZ-D 30mg/40mg Capsule PR:
Follow your physician's instructions or consult the product label for usage guidance. Administer PNZ-D 30mg/40mg Capsule PR on an empty stomach.
How PNZ-D 30mg/40mg Capsule PR works:
Each PNZ-D 30mg/40mg capsule contains Domperidone and Pantoprazole, two medications working synergistically. Domperidone, a prokinetic agent, enhances gastrointestinal motility, facilitating smoother food passage. Pantoprazole, a proton pump inhibitor (PPI), lessens stomach acid production, providing relief from heartburn and acid indigestion.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when using PNZ-D 30mg/40mg Capsule PR concurrently with alcohol. Seek medical advice.
PregnancyCONSULT YOUR DOCTOR
The use of PNZ-D 30mg/40mg capsules during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingCAUTION
The administration of PNZ-D 30mg/40mg capsules requires careful consideration while breastfeeding. Mothers should discontinue breastfeeding for the duration of their treatment and until the medication is fully cleared from their system.
DrivingUNSAFE
Taking a PNZ-D 30mg/40mg capsule might cause drowsiness, blurred vision, or dizziness. Refrain from driving if you experience these effects.
KidneyCAUTION
Patients with kidney impairment should exercise caution when using PNZ-D 30mg/40mg Capsule PR. Dosage modification of PNZ-D 30mg/40mg Capsule PR might be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
The use of PNZ-D 30mg/40mg Capsule PR in patients with hepatic impairment is likely safe. Current evidence indicates dose modification may be unnecessary, though data is limited. Physician consultation is recommended.
What if you forget to take PNZ-D 30mg/40mg Capsule PR :
Should you forget a PNZ-D 30mg/40mg Capsule PR dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About PNZ-D 30mg/40mg Capsule PR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
